Intensity Therapeutics In...

NASDAQ: INTS · Real-Time Price · USD
0.33
-0.25 (-43.01%)
At close: Jun 12, 2025, 3:59 PM

Intensity Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.59M 8.56M 1.31M 4.54M
Short-Term Investments
n/a 6.22M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.3M 1.68M 167.74K 167.74K
Receivables
n/a n/a 62.3K 51.26K
Inventory
n/a n/a 29.36K 70.44K
Other Current Assets
n/a 6K 46.8K 69.28K
Total Current Assets
3.36M 15.46M 1.45M 4.73M
Property-Plant & Equipment
122K 147K 139.09K 318.13K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.42M 1.83M 306.83K 485.86K
Total Assets
4.78M 17.3M 1.76M 5.22M
Account Payables
1.22M 3.05M 603K 172.51K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
28K n/a 4.35M 2.02M
Other Current Liabilities
56K 499K -655 n/a
Total Current Liabilities
1.75M 3.96M 6.82M 3.72M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 36K 10.04M 10.04M
Total Long-Term Liabilities
110K 174K 10.04M 10.18M
Total Liabilities
1.86M 4.13M 16.85M 13.9M
Total Debt
138K 158K 4.49M 2.34M
Common Stock
2K 1K 341.00 682.00
Retained Earnings
-66.78M -50.52M -38.65M -31.07M
Comprehensive Income
n/a n/a n/a -31.07M
Shareholders Equity
2.92M 13.16M -15.1M -8.68M
Total Investments
n/a 6.22M n/a n/a